Document is current
Any future updates will be listed below
-
Authors
Rexwinkel, Robyn
Vermeijden, Nicolaas Koen
Zeevenhooven, Judith
Kelder, Johannes
Groeneweg, Michael
Hummel, Thalia
Goede, Joery
van Wering, Herbert
Stapelbroek, Janneke
Benninga, Marc
Vlieger, Arine
- License Information
-
More Information
Article History
Received: 22 October 2024
Revised: 23 December 2024
Accepted: 20 January 2025
First Online: 11 February 2025
Declarations
:
: All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The medical ethics committee of the Amsterdam UMC (MEC AMC 018) and the Dutch Central Committee on Research Involving Human Subjects (CCMO) approved the study. Moreover, the study was approved by the local ethics committees of all recruiting sites.
: Informed consent was obtained from all individual participants and/or legal guardians included in the study.
: Robyn Rexwinkel, Nicolaas Vermeijden, Judith Zeevenhooven, Johannes Kelder, Michael Groeneweg, Thalia Hummel, Joery Goede, Herbert van Wering, Janneke Stapelbroek, and Arine Vlieger: no conflicts of interest. Marc Benninga is consultant for Shire, Norgine, Coloplast, Danone, Takeda, Allergan, Shire, Abbvie, Sensus, FrieslandCampina, United Pharmaceuticals, Hip.
